top-public-research-management-company
,

Project Spotlight: Southeast Asia Biosurveillance and Epidemiology Research

The Problem:

The current global disease control strategy is focused almost entirely on responding to pandemics after they have emerged, leaving the global community vulnerable to rising human health threats. The emergence of Ebola and the Middle East Respiratory Syndrome serve as poignant examples. Considering the speed at which these types of infectious diseases can spread across the globe, the development of systems to prevent pandemics and to detect emerging threats early on is vitally important. In today’s world of global trade and air travel, the exponential rate through which pathogens can spread from one human to thousands across continents in a single day is of crucial concern, increasing the necessity for proactive and globally integrated pandemic response systems.

The Work:

NAMRU-2 is a leader in the U.S. Department of Defense’s disease surveillance efforts.  They are well-positioned to evaluate novel diagnostics products and therapeutic interventions, test disease control strategies, and to develop local expertise to detect and respond to emergent disease threats.

The Vysnova Impact:

As a contractor working with the U.S. Navy, Vysnova works to ensure full engagement of in-country collaborators and provides comprehensive program support to enhance biosurveillance and biosafety capacity building across study sites in Southeast Asia. The Vysnova team provides technical and managerial support to a plethora of cohort and surveillance studies across the Southeast Asia region in order to investigate and better understand vector-borne febrile and respiratory illnesses. Vysnova provides in-country staff to NAMRU-2 to assist in task completion tracking, develop and maintain data repositories, collaborate with local implementation partners and research institutes, and supply direct administrative and IT support to NAMRU-2. From our Washington, D.C.-based project office, Vysnova provides higher-level program-wide support by tracking study progress, overseeing contract compliance, and liaising with Principal Investigators to facilitate discussions on strategic directions of the research. Our collaborative and solution-based approach allows NAMRU-2 investigators to focus on the critical science at hand, developing strategies for combating future infectious disease threats to human health.

 

top-public-research-management-company
,

Vysnova Partners Awarded the SABER II Program

Vysnova Partners, Inc. awarded the 
Southeast Asia Biosurveillance and Epidemiology
Research (
SABER) II Program

 

Landover, MD September 13, 2018

Vysnova Partners, a global health project management firm, was recently awarded the Southeast Asia Biosurveillance and Epidemiology Research (SABER) II program to provide support for the Naval Medical Research Unit 2 (NAMRU-2) based in Singapore. Vysnova is currently the holder of the program’s precursory contract. SABER II is a single award IDIQ with a $38 million ceiling. It provides support for NAMRU-2 to evaluate novel diagnostics products and therapeutic interventions, test disease control strategies, and develop local expertise to detect and respond to emergent disease threats.  As the holder of the contract, Vysnova will support the ongoing development, performance and management of research across the Southeast Asia region in collaboration with host-country partners.

The SABER II contract ensures the continuation of our efforts to understand and combat malaria, Zika, MERS-CoV, and other vector-born illnesses. In addition to working with NAMRU-2 to develop preventative measures against infectious diseases and improve disease surveillance efforts, Vysnova is also working with NAMRU-2 under the Operational Research Support Across Southeast Asia to specifically target malaria infection. Some of Vysnova’s other work in this field includes helping to conduct malaria indicator surveys as a subcontractor to ICF under the seventh phase of the Demographic and Health Survey (DHS) Program for the U.S. Agency for International Development (USAID). Furthermore, Vysnova works with the Department of Health and Human Services at the Center for Disease Control and Prevention (CDC) to work with in-country partners in South America to perform testing and enhance surveillance in order to better understand and fight Zika infection in pregnant women and their children.

Vysnova is honored to continue to work with our in-country partners and the Navy in reducing and preventing infectious diseases and improving the health of communities in Southeast Asia.